• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Vismodegib treatment in a HIV positive patient on antiretroviral therapy.

作者信息

Scalvenzi Massimiliano, Villani Alessia, Mazzella Caterina, Cappello Milena, Salvatores Gaia De Fata, Costa Claudia

机构信息

Department of Dermatology, University of Naples Federico II, Naples, Italy.

出版信息

Indian J Dermatol Venereol Leprol. 2018 Nov-Dec;84(6):758-760. doi: 10.4103/ijdvl.IJDVL_92_18.

DOI:10.4103/ijdvl.IJDVL_92_18
PMID:30226476
Abstract
摘要

相似文献

1
Vismodegib treatment in a HIV positive patient on antiretroviral therapy.在接受抗逆转录病毒治疗的HIV阳性患者中使用维莫德吉进行治疗。
Indian J Dermatol Venereol Leprol. 2018 Nov-Dec;84(6):758-760. doi: 10.4103/ijdvl.IJDVL_92_18.
2
A Novel Alternate Dosing of Vismodegib for Treatment of Patients With Advanced Basal Cell Carcinomas.维莫德吉治疗晚期基底细胞癌患者的一种新型交替给药方案。
JAMA Dermatol. 2017 Apr 1;153(4):321-322. doi: 10.1001/jamadermatol.2016.5058.
3
Vismodegib Efficacy in Advanced Basal Cell Carcinoma Maintained with 8-Week Dose Interruptions: A Model-Based Evaluation.维莫德吉在晚期基底细胞癌中的疗效：基于模型的评估，8周剂量中断后疗效得以维持
J Invest Dermatol. 2021 Apr;141(4):930-933. doi: 10.1016/j.jid.2020.07.036. Epub 2020 Sep 22.
4
PRISModegib: the use of the PRISM test to assess the health-related quality of life of patients with locally advanced basal cell carcinoma undergoing Hedgehog pathway inhibitor therapy.PRI模式吉莫单抗：使用PRISM测试评估接受Hedgehog通路抑制剂治疗的局部晚期基底细胞癌患者的健康相关生活质量。
Br J Dermatol. 2019 Aug;181(2):406-407. doi: 10.1111/bjd.17754. Epub 2019 May 6.
5
BCC and vismodegib: can we treat and remold at the same time?基底细胞癌与维莫德吉：我们能否同时进行治疗和重塑？
G Ital Dermatol Venereol. 2020 Feb;155(1):119-120. doi: 10.23736/S0392-0488.18.06043-1. Epub 2018 May 16.
6
Outcomes for Basal Cell Carcinoma Treated With Vismodegib Extended Alternate Day Dosing.维莫德吉延长隔日给药治疗基底细胞癌的疗效
Dermatol Surg. 2020 Aug;46(8):1109-1112. doi: 10.1097/DSS.0000000000001985.
7
Vismodegib for the treatment of aggressive basal cell carcinoma in a patient unable to swallow pills.维莫德吉用于治疗无法吞咽药丸的侵袭性基底细胞癌患者。
Dermatol Surg. 2015 Mar;41(3):433-5. doi: 10.1097/DSS.0000000000000299.
8
Effective and Tolerable Treatment of Advanced Basal Cell Carcinoma With Vismodegib Despite Renal Insufficiency.尽管存在肾功能不全，维莫德吉对晚期基底细胞癌仍有有效且可耐受的治疗效果。
JAMA Dermatol. 2016 Dec 1;152(12):1387-1388. doi: 10.1001/jamadermatol.2015.4592.
9
Efficacy and safety of vismodegib in patients with basal cell carcinoma: An Italian Center experience.维莫德吉治疗基底细胞癌患者的疗效与安全性：意大利某中心的经验
Dermatol Ther. 2019 Jul;32(4):e12971. doi: 10.1111/dth.12971. Epub 2019 Jun 12.
10
Concurrent Vismodegib and Radiotherapy for Recurrent, Advanced Basal Cell Carcinoma.维莫德吉与放疗联合治疗复发性、晚期基底细胞癌。
JAMA Dermatol. 2015 Sep;151(9):998-1001. doi: 10.1001/jamadermatol.2015.0326.

引用本文的文献

1
The Efficacy of Sonidegib in Treating Locally Advanced Basal Cell Carcinoma Involving the Periocular Area.索尼德吉治疗累及眼周区域的局部晚期基底细胞癌的疗效
Dermatol Ther (Heidelb). 2023 Sep;13(9):2121-2126. doi: 10.1007/s13555-023-00985-1. Epub 2023 Jul 21.
2
Management of Advanced Invasive Melanoma: New Strategies.晚期侵袭性黑色素瘤的治疗管理：新策略。
Adv Ther. 2023 Aug;40(8):3381-3394. doi: 10.1007/s12325-023-02555-5. Epub 2023 Jun 12.
3
Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature.
新冠疫苗接种后的皮肤反应：当前文献综述
Clin Cosmet Investig Dermatol. 2022 Nov 6;15:2369-2382. doi: 10.2147/CCID.S388245. eCollection 2022.
4
Non-Melanoma Skin Cancer in People Living With HIV: From Epidemiology to Clinical Management.感染艾滋病毒者的非黑色素瘤皮肤癌：从流行病学到临床管理
Front Oncol. 2021 Aug 4;11:689789. doi: 10.3389/fonc.2021.689789. eCollection 2021.
5
Hair Loss in Patients Treated with Vismodegib: A Single-Center Retrospective Study.维莫德吉治疗患者的脱发：一项单中心回顾性研究。
Skin Appendage Disord. 2020 Sep;6(5):280-282. doi: 10.1159/000508825. Epub 2020 Aug 5.
6
Sonidegib: Safety and Efficacy in Treatment of Advanced Basal Cell Carcinoma.索尼德吉：治疗晚期基底细胞癌的安全性与有效性
Dermatol Ther (Heidelb). 2020 Jun;10(3):401-412. doi: 10.1007/s13555-020-00378-8. Epub 2020 Apr 15.
7
Low-Dose Vismodegib as Maintenance Therapy After Locally Advanced Basal Cell Carcinoma Complete Remission: High Efficacy with Minimal Toxicity.低剂量维莫德吉作为局部晚期基底细胞癌完全缓解后的维持治疗：高效且毒性极小。
Dermatol Ther (Heidelb). 2020 Jun;10(3):465-468. doi: 10.1007/s13555-020-00371-1. Epub 2020 Apr 2.
8
Long-Term Efficacy of Vismodegib After its Withdrawal and Patients' Health-Related Quality of Life Using the Dermatology Life Quality Index (DLQI).维莫德吉停药后的长期疗效以及使用皮肤病生活质量指数（DLQI）评估患者的健康相关生活质量。
Dermatol Ther (Heidelb). 2019 Dec;9(4):719-724. doi: 10.1007/s13555-019-00323-4. Epub 2019 Sep 10.
9
Real-Life Effectiveness of Vismodegib in Patients with Metastatic and Advanced Basal Cell Carcinoma: Characterization of Adverse Events and Assessment of Health-Related Quality of Life using the Dermatology Life Quality Index (DLQI) Test.维莫德吉在转移性和晚期基底细胞癌患者中的实际疗效：不良事件特征及使用皮肤病生活质量指数（DLQI）测试评估健康相关生活质量
Dermatol Ther (Heidelb). 2019 Sep;9(3):505-510. doi: 10.1007/s13555-019-0303-4. Epub 2019 Jun 4.